Announcements Trials

Browse Landscape

Status

Completed 126 Terminated 20 Unknown 17 Active not recruiting 15 Recruiting 10 Withdrawn 9 Not yet recruiting 3 Enrolling by invitation 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, Mantle-Cell 1

Interventions

pirtobrutinib 1 ibrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Lymphoma, Mantle-Cell × Cyclophosphamide × Clear all

NCT04162756 2021-10-14

ZUMA-18

Gilead Sciences

Approved for marketing

Recurrence, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡